1. Neuronal lipolysis prevents LD accumulation in neurons.
Introduction
Lipid droplets (LDs) are dynamic cytoplasmic organelles which are present in most, if not all, eukaryotic cells and many prokaryotic cells. By storing excess lipids in the form of neutral lipids including triacylglycerol (TAG) and sterol ester (SE), LDs maintain cellular lipid homeostasis, along with the coordinated actions of lipogenesis and lipolysis (Chen, Chen et al., 2019 , Olzmann & Carvalho, 2019 ). The nervous system, including neurons and glia, has a high concentration of lipids.
However, LDs in the nervous system are generally found in glial cells but not in neurons under normal conditions in vivo (Kis, Barti et al., 2015) .
The origin and the role of glial LDs have been investigated only in recent years. The formation of LDs in glia, which act as a niche for neuroblasts, preserves Drosophila larval neuroblast proliferation under ROS-inducing stress conditions such as hypoxia. It is postulated that the incorporation of polyunsaturated fatty acids (PUFAs) into neutral lipids, and their storage in LDs, reduces the ROS insult and the toxic peroxidation of PUFAs in neuroblasts (Bailey, Koster et al., 2015) . Several other studies reported the neuronal origin of glial LDs. When Drosophila neurons are under ROS insult or have mitochondrial dysfunction, neuronal lipid production is increased through SREBP-mediated lipogenesis. Interestingly, instead of forming LDs in neurons, lipids are transferred to neighboring glia through fatty acid transfer protein (FATP) or apolipoprotein to form LDs (Liu, MacKenzie et al., 2017 , Liu, Zhang et al., 2015 . In cultured hippocampal neurons, hyperactivated neurons also produce excess fatty acids, which are transferred, via lipid particles associated with ApoE, to astrocytes and are incorporated into LDs. The storage of fatty acids in astrocyte LDs and their subsequent -oxidation in mitochondria protects neurons during periods of enhanced activity (Ioannou, Jackson et al., 2019) . These findings suggest that LD formation in glia plays a role in protecting neurons from stress insults. However, it is unknown why neurons do not form LDs in an autonomous fashion to protect themselves under stress conditions. Although neurons do not normally have LDs, some neuronal diseases are associated with LD biology and neuronal LDs have been reported in some disease models. The Parkinson's disease protein -Synuclein is located on the surface of LDs and -Synuclein expression is correlated with LD accumulation (Cole, Murphy et al., 2002 , Outeiro & Lindquist, 2003 . Huntington's disease cells, including primary striatal neurons and glia in Huntington's disease mice, have dramatically increased LDs (Martinez-Vicente, Talloczy et al., 2010) . Several hereditary spastic paraplegia (HSP) proteins affect LD dynamics, such as Spartin, spastin, atlastin-1, seipin and REEP1 (Ding, Yang et al., 2018 , Eastman, Yassaee et al., 2009 , Ebihara, Ebihara et al., 2015 , Klemm, Norton et al., 2013 , Papadopoulos, Orso et al., 2015 , Renvoise, Malone et al., 2016 . Despite the apparent association between LD and neuronal diseases, the causal link between neuronal LD dynamics and neuronal disorders remains largely elusive.
In this study, we explored the dynamics and the physiological role of LDs in neurons. Using C. elegans as a model, we found that ATGL-1/LID-1-mediated lipolysis autonomously regulates neuronal LD dynamics. ATGL-1 is the C. elegans homolog of mammalian ATGL, the rate-limiting enzyme of TAG hydrolysis, and LID-1 is the C. elegans homolog of mammalian CGI-58 (also named as ABHD5), which is the best known co-activator of ATGL (Lass, Zimmermann et al., 2006) .
Mutations in either CGI-58 or ATGL lead to neutral lipid storage disease (NLSD) with neurological abnormalities in human (Massa, Pozzessere et al., 2016 , Schweiger, Lass et al., 2009 . Importantly, defective neuronal lipolysis reduces PUFA-mediated touch sensation and protects neurons from hyperactivation-triggered neurodegeneration. The neuronal protective effect of atgl-1 mutants is significantly enhanced by reduction of de novo PUFA synthesis and/or incorporation of PUFAs into phospholipids. Together, our results show that neuronal LDs participates in PUFA-mediated neural functions and neurodegeneration.
Results

LDs accumulate in neurons of both atgl-1 and lid-1 mutants
To observe LDs in worm neurons, we generated a neuron-specific GFP reporter line xdIs109 expressing the LD surface protein PLIN1. PLIN1::GFP forms ring-like structures when expressed in tissues with LDs (Bi, Xiang et al., 2012 , Liu, Li et al., 2014 . In xdIs109 animals, we mainly focused on the head region, which is the location of most neuronal soma. We found that there are very few GFP rings in xdIs109 young adults (Fig. 1A) . This indicates that similar to mammals, there are few LDs in C. elegans neurons under normal conditions. It has been reported that both aging and general obesity may increase LD accumulation in non-adipose tissues (Palikaras, Mari et al., 2017 , Shimabukuro, Langhi et al., 2016 , Zhou, Grayburn et al., 2000 .
To explore the influence of aging and overall fat content increase on neuronal LDs, we examined the xdIs109 GFP pattern in 8-day-old wild-type adults, daf-2(e1370) mutants and glp-1(e2141) mutants.
It is well known that the latter two mutants have an overall increase in lipid storage (O'Rourke, Soukas et al., 2009) . We found that compared to young xdIs109 controls, there is no significant increase of LD number in 8-day-old xdIs109, daf-2(e1370); xdIs109 and glp-1(e2141); xdIs109 (Fig.   1B ). This indicates that aging and general obesity do not necessarily result in neuronal LD accumulation.
To reveal the underlying mechanism(s) that control LD dynamics in neurons, we performed an EMS screen using the xdIs109 marker to search for mutants with neuronal LD accumulation. We isolated the xd288, xd310 and xd314 mutants, which show LDs in many neurons in the head region, ventral nerve cord and tail ( Fig. 1A) . We also quantified LDs in the head region, and found that the number of LDs is increased significantly in these mutants ( Fig. 1B) .
Complementation tests divided these three mutants into two complementation groups. xd288 complements both xd310 and xd314, while xd310 fails to complement xd314. Through SNP mapping, we narrowed down the region of the xd288 mutation to chromosome I between +3.85 cM and +5.05 cM. Through fosmid transgenic rescue assays, we found that the WRM0632aE01 fosmid fully rescues the neuronal LD phenotype of xd288. The gene lid-1 (lipid droplet protein 1), which encodes one of the C. elegans homologs of mammalian CGI-58, is found in this fosmid (Lee, Kong et al., 2014) . Importantly, we found a C332T point mutation in lid-1, and this mutation leads to a missense S111L mutation of LID-1 (Fig. 1C ). S111 is located in the putative α/β hydrolase domain of LID-1 and is conserved in C. elegans, Drosophila, mouse and human ( Fig. S1A ). Interestingly, S111 of LID-1 corresponds to S115 in human, which is mutated in NLSD (Ben Selma, Yilmaz et al., 2007) .
A previous report showed that LID-1 binds to the C. elegans ATGL homolog, ATGL-1, and promotes ATGL-1-dependent lipolysis during fasting conditions (Lee et al., 2014) . As expected, we found that xd310 and xd314 are mutants of C. elegans atgl-1. The xd310 mutation causes a missense G210E change, while xd314 causes a missense G19R change in ATGL-1 ( Fig. 1D ). G19 of ATGL-1 is conserved in C. elegans, Drosophila, mouse and human (Fig. S1B) . The G19R and G210E mutations are located in an active (α/β/α) sandwich domain of ATGL-1, which is responsible for its enzymatic activity. Oil red O staining shows that both lid-1(xd288) and atgl-1(xd314) have more fat than controls, especially in the head region ( Fig. 1E ) and intestine (Fig. S1C ). This suggests that, just like in NLSD, the overall fat content is increased in lid-1 and atgl-1 mutants. The recessive nature of the xd288, xd310 and xd314 mutations and the lipolytic function of ATGL and CGI-58 suggest that defective lipolysis leads to LD accumulation in neurons.
These mutants were isolated based on the appearance of neuronal LDs in the xdIs109 background. To avoid potential interference from the overexpression of PLIN1::GFP, we used electron microscopy (EM) to observe neurons in lid-1(xd288) and atgl-1(xd314) animals without the xdIs109 marker. LDs were easily found in the neuronal soma of xd288 and xd314 mutants, but not in wild type (Fig. 1F ). We could even trace whole LDs in mutants from continuous EM serial sections ( Fig. 1G ). This demonstrates that atgl-1(xd314) and lid-1(xd288) mutants indeed have ectopic LDs in neurons.
atgl-1 autonomously regulates neuronal LDs
ATGL-1 is expressed strongly in worm intestine (Lee et al., 2014) , but its expression in neurons has not been reported in detail. To observe the expression pattern of ATGL-1, we first mapped the promotor of atgl-1. The excess neuronal LD phenotype of atgl-1(xd314) was fully rescued by several overlapping atgl-1(+) fosmids. The overlapping region of the rescuing fosmids highlights a 3.4 Kb promoter region which may be important for the rescuing activity. We further found that an atgl-1 genomic fragment with a 3 Kb promoter fully rescues the neuronal LD phenotype of atgl-1(xd314) ( Fig. S2A and B ). Using this 3 Kb promoter region to drive a GFP reporter, we examined the expression pattern of atgl-1 in detail. The GFP fluorescence is bright in the intestine, consistent with a previous report (Lee et al., 2014) . We also found weak expression in neurons in the nerve ring, ventral nerve cord and tail ( Fig. 2A ).
To specifically analyze ATGL-1 expression in neurons, we used the self-complementing split GFP system. Split GFP is composed of two separate GFP fragments (a 15-amino acid fragment, GFP11, and a 215-amino acid fragment, GFP1-10), which are expressed separately and are able to associate spontaneously to form fluorescent GFP (Cabantous, Terwilliger et al., 2005) . As controls, transgenic animals expressing either Patgl-1::GFP1-10 or pan-neuronal Prab-3::GFP11 do not exhibit GFP fluorescence (Fig. 2B ). The GFP fluorescence is clearly seen in neurons, including head region, ventral nerve cord and tail neurons, in animals expressing both Patgl-1::GFP1-10 and panneuronal Prab-3::GFP11 (Fig. 2B ). This result provides further evidence for the neuronal expression of ATGL-1.
To investigate whether atgl-1 functions autonomously or non-autonomously, we performed tissue-specific rescue and tissue-specific knockout experiments. We found that neuronal Punc-119::atgl-1 expression, but not glial Phlh-17::atgl-1, hypodermal Pajm-1::atgl-1 or intestinal Pvha-6::atgl-1 expression, rescues the neuronal LD phenotype of atgl-1(xd314); xdIs109 ( Fig. 2C and D) .
We also generated a neuron-specific knockout of atgl-1 using the Cre-loxP system. We first used CRISPR-Cas9 to insert two loxP sites flanking the atgl-1 coding region, and then we expressed Cre in neurons to specifically knock out atgl-1 in neurons ( Fig. S2C ). We found that similar to atgl-1(xd314) mutants, neuronal-specific deletion of atgl-1 [atgl-1-loxP(xd426) ; xdIs182 (Prab-3::Cre/Podr-1::RFP)] causes LD accumulation in neurons ( Fig. 2E and F ). Together, these results demonstrate that ATGL-1 acts autonomously in neurons to prevent neuronal LD accumulation.
Paralogs of ATGL-1 and LID-1 do not affect neuronal LD dynamics
The above results indicate that ATGL-1/LID-1-mediated lipolysis prevents the appearance of visible LDs in neurons. In contrast to lipolysis, lipogenesis promotes lipid storage. We wondered whether overexpression of lipogenesis-related genes in neurons could cause LD accumulation. DGAT1 and DGAT2 are key enzymes in the synthesis of TAG from diacylglycerol (DAG) (Fig. 3A) . DGAT1 has only one homolog, MBOA-2, in C. elegans . DGAT2 has four homologs (DGAT-2/F59A1.10, K07B1.4, DGTR-1/W01A11.2 and Y53G8B.2) in C. elegans (Fig. 3B ). We pan-neuronally overexpressed mboa-2 or K07B1.4. In these transgenic animals, there are ectopic LDs in neurons as revealed by the xdIs109 reporter ( Fig. 3C ). Therefore, both elevating lipogenesis or reducing lipolysis leads to LD accumulation in neurons. Together, these results indicate that neurons have the ability to form and hydrolyze LDs. The lack of visible LDs in neurons reflects the dominance of lipolysis over lipogenesis under normal conditions. There are two LID-1 paralogs (C37H5.2 and C37H5.3) and two ATGL-1 paralogs (B0524.2 and D1054.1) in C. elegans (Fig. 3D ). Although LID-1 is reported to regulate lipolysis by interacting with ATGL-1 (Lee et al., 2014) , C37H5.3, also named as cgi-58, had been shown to promote ATGL-1 activity at the dauer stage when the protein stability of ATGL-1 is negatively regulated via phosphorylation by AMPK (Narbonne & Roy, 2009 , Xie & Roy, 2015a , Xie & Roy, 2015b . To test whether ATGL-1 and LID-1 paralogs affect LD homeostasis in neurons, we examined the neuronal LD phenotypes of C37H5.2(ok3722), C37H5.3(ok3245), D1054.1(tm3111) and B0524.2(tm6739) mutants with the xdIs109 marker. Similar to wild type, there are almost no LDs in neurons in these mutants ( Fig. 3E ). These mutants are all deletion alleles (Fig. S3 ), and even though we are not sure whether they are null alleles, their phenotypes indicate that the ATGL-1/LID-1 pair plays the main role in regulating neuronal lipolysis and neuronal LD dynamics.
Next, we explored whether these paralogs can substitute for ATGL-1 or LID-1 in neurons. We overexpressed these paralogs in neurons specifically to examine whether they could rescue the neuronal LD phenotype of atgl-1(xd314); xdIs109 or lid-1(xd288); xdIs109. Because these paralogs may function in pairs, like ATGL-1 and LID-1, we overexpressed all four paralogs together in neurons. We found that they could not rescue the neuronal LD phenotype of either atgl-1(xd314); xdIs109 or lid-1(xd288); xdIs109 ( Fig. 3F ). Together, these results indicate the importance and the specificity of the ATGL-1/LID-1 partnership in regulating neuronal LD dynamics.
atgl-1 and lid-1 affect gentle touch sensation and genetically interact with the de novo PUFA biosynthesis pathway
The above results show that lipolysis restricts the appearance of visible LDs in neurons. We next examined the neuronal consequence of defective lipolysis. LDs are temporary storage places for excess lipids. Since lipids are important building blocks for membranes, we initially focused on examining whether atgl-1 affects neuronal morphology. The PVD neuron has very complex neurites, especially dendrites, which may require lots of lipids for membrane biogenesis. We did not find any morphological difference between wild type and atgl-1(xd314) or lid-1(xd288) mutants based on observations with the PVD marker wdIs52(PF49H12.4::GFP) ( Fig. S4 ). This suggested that the appearance of LDs may not affect the gross morphology of neurons.
A previous report showed that when PUFAs are diverted away from membranes to the core of LDs, the expansion of LDs inhibits the oxidation of PUFAs and reduces the toxic effect of PUFAs (Bailey et al., 2015) . Therefore, the presence of LDs in neurons may limit the availability of PUFAs and affect PUFA-associated neuronal events. PUFAs affect the gentle touch sensation and mechanoelectrical transduction in C. elegans touch receptor neurons (Kahn-Kirby, Dantzker et al., 2004 , Vasquez, Krieg et al., 2014 . There are ectopic LDs in touch neurons in atgl-1(xd314) as revealed by stimulated Raman scattering (SRS) microscopy ( Fig. 4A ). To examine whether the gentle touch sensation is affected in atgl-1(xd314) and lid-1(xd288) mutants, we measured the touch sensitivity by a ten-trial touch assay (Hart, 2006) . mec-4(u253) and N2 were used as the positive control and negative control, respectively. Compared to the strong touch sensation defect in mec-4(u253) mutants, touch sensation is partially impaired in atgl-1(xd314) and lid-1(xd288) mutants. Importantly, expression of neuronal specific Punc-119::atgl-1 and Punc-119::lid-1 fully rescued the touch sensation defect in atgl-1(xd314) and lid-1(xd288), respectively (Fig.4B ). This suggests that neuronal lipolysis is required for normal gentle touch sensation.
In the de novo PUFA biosynthetic pathway, fat-4 is responsible for the synthesis of arachidonic acid (AA, C20:4 (20 carbons with four double bonds)) and eicosapentaenoic acid (EPA, C20:5) ( Fig.4C ) (Watts & Browse, 2002) . Mutation of fat-4 leads to mild gentle touch sensation defects similar to those in atgl-1(xd314) and lid-1(xd288) mutants ( Fig.4B ) (Vasquez et al., 2014) . We then investigated the genetic relationship between ATGL-1/LID-1-mediated lipolysis and de novo synthesis of PUFAs by double mutant analysis. Interestingly, the fat-4(wa14) mutation enhances the touch sensation defect of both atgl-1(xd314) and lid-1(xd288) single mutants ( Fig. 4B ), which suggests that ATGL/LID-1-regulated neuronal lipolysis participates in PUFA-mediated touch sensation.
atgl-1(xd314) and lid-1(xd288) mutants have reduced neuron hyperactivation-triggered neurodegeneration
Glial LDs are reported to be involved in neurodegeneration in Drosophila (Liu et al., 2017 , Liu et al., 2015 . In particular, to avoid fatty acid toxicity in hyperactivated neurons, fatty acids are transported from neurons into glia and stored in LDs before detoxification through mitochondrial oxidation (Ioannou et al., 2019) . These findings prompted us to investigate whether the appearance of neuronal LDs in atgl-1 and lid-1 mutants alleviates neurodegeneration. mec-4 encodes the ion channel protein MEC-4 and dominant negative mutants of mec-4, often referred to as mec-4(d), have been widely used as models of neuron hyperactivation-triggered neurodegeneration (Calixto, Jara et al., 2012 , Driscoll & Chalfie, 1991 . The neurodegeneration in mec-4(d) occurs as early as the embryonic stage, and by the L4 stage the majority (63 ± 2%) of mec-4(d) animals only have two touch neurons left as viewed by the zdIs5 marker, which labels six touch sensory neurons in wild type (Fig. 5A ). We found that atgl-1 mutation reduces the neuronal degeneration of mec-4(d) ( Fig. 5A and B) .
Specifically, the proportion of animals with three or more surviving touch neurons increased from 6 ± 1% in mec-4(d) to 28 ± 1% in atgl-1(xd314); mec-4(d) worms ( Fig. 5C ). Similarly, lid-1 mutation also reduced the neuronal loss of mec-4(d). The proportion of animals with three or more surviving touch neurons increased to 23 ± 2% in lid-1(xd288); mec-4(d) worms ( Fig. 5C ). Moreover, the reduction of mec-4(d)-triggered neurodegeneration by atgl-1 and lid-1 mutations can be reversed by neuronal specific expression of wild-type atgl-1 and lid-1, respectively (Fig. 5C ). These data indicate that defective neuronal lipolysis reduces neuron hyperactivation-triggered neurodegeneration.
Defects in neuronal lipolysis and de novo PUFA biosynthesis synergistically decrease the neuronal loss caused by mec-4(d)
Hyperactivated neurons are vulnerable because the peroxidation of fatty acids, in particular PUFAs, can result in neurodegeneration (Ioannou et al., 2019) . fat-1, fat-3 and fat-4 encode key enzymes for de novo synthesis of different PUFAs in C. elegans (Watts & Browse, 2002 , Watts & Ristow, 2017 .
Consistent with the potential involvement of PUFAs in neuron hyperactivation-triggered neurodegeneration, we found that mec-4(d)-triggered neurodegeneration was significantly reduced in fat-4(wa14) and fat-3(wa22) mutants but not fat-1(wa9) (Fig. 5D ). The proportion of animals that with three or more surviving touch neurons increased from 6 ± 1% in mec-4(d) to 35 ± 1% in fat-4(wa14); mec-4(d) and 43 ± 3% in fat-3(wa22); mec-4(d) worms. These results indicate that reducing the biosynthesis of PUFAs alleviates the neuronal loss of mec-4(d).
Since ATGL-1/LID-1-mediated neuronal lipolysis is involved in PUFA-mediated touch sensation ( Fig. 5A and B) , and both atgl-1 and lid-1 mutants have reduced mec-4(d)-induced neurodegeneration ( Fig. 4B ), we next explored the neuroprotective effect of double mutations in neuronal lipolysis and de novo synthesis of PUFAs. Interestingly, atgl-1(xd314); fat-1(wa9), atgl-1(xd314); fat-3(wa22) and atgl-1(xd314); fat-4(wa14) double mutants all have significantly reduced mec-4(d)-triggered neurodegeneration compared to single mutants (Fig. 5D ). The proportion of animals with three or more surviving touch neurons increased from 6 ± 1% in mec-4(d) to 52 ± 3% in fat-1(wa9); atgl-1(xd314); mec-4(d), 78 ± 2% in fat-4(wa14); atgl-1(xd314); mec-4(d) and 77 ± 1% in fat-3(wa22); atgl-1(xd314); mec-4(d) worms. Therefore, blocking de novo PUFA synthesis and neuronal lipolysis together greatly protects neurons from degeneration caused by mec-4(d).
The PUFAs AA and EPA promote the neurodegeneration of mec-4(d)
Since fat-3(wa22) and fat-4(wa14) show similar neural protection phenotypes ( Fig 5D) , we reasoned that PUFAs, such as AA (C20:4, n-6) and EPA (C20:5, n-3) or their derivatives, may promote mec-4(d)-induced neurodegeneration. We fed worms on NGM medium supplemented with different fatty acids. fat-4(wa14); mec-4(d) and fat-4(wa14); atgl-1(xd314); mec-4(d) animals show a significant increase of neurodegeneration when grown in AA-supplemented NGM compared with normal NGM (Fig. 5E ). Feeding worms with EPA, but not linoleic acid (LA, C18:2), had a similar effect (Fig. 5E ).
In contrast, feeding worms with a mixture containing two saturated fatty acids (palmitic acid (PA, C16:0) and stearic acid (SA, C18:0)) and one monounsaturated fatty acid (oleic acid (OA, C18:1)) did not affect the neurodegeneration phenotype in fat-4(wa14); mec-4(d) and fat-4(wa14); atgl-1(xd314); mec-4(d) (Fig. S5 ). These results indicate that the PUFAs AA and EPA promote the neurodegeneration of mec-4(d).
PUFAs promote neurodegeneration through incorporation into phospholipids
Elevated ROS is proposed to be a key event for neurodegeneration triggered by neuron hyperactivation in both C. elegans and mammals (Calixto et al., 2012 , Ioannou et al., 2019 , Sangaletti, D'Amico et al., 2017 . We then tested whether ROS contributes to PUFA-mediated neurodegeneration. We found that sod-2 mutation did not significantly decrease the number of surviving neurons in atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d), or fat-4(wa14); atgl-1(xd314); mec-4(d) (Fig. S6A ). Furthermore, overexpression of the ROS scavenger SOD-1, SOD-2, SOD-3 or SOD-4 in touch neurons did not affect mec-4(d)-triggered neurodegeneration (Fig. S6B ). Moreover, when we fed mec-4(d) mutants with the antioxidant N-acetylcysteine (NAC), the survival of neurons was still not significantly increased (Fig. S6C ). In addition, there was no change in the number of surviving neurons in atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d) following treatment with N-acetylcysteine (NAC) (Fig. S6C ). Therefore, ROS may not play a major role in neuronal lipolysis and PUFA-mediated neuronal loss caused by mec-4(d).
To further investigate how PUFAs promote neurodegeneration, we performed a lipidomic analysis of mec-4(d), atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and fat-4(wa14); atgl-1(xd314); mec-4(d) to find correlations between the level of PUFA-containing lipids and the severity of neurodegeneration. In fat-4 mutants, C20:3 or C20:4-containing lipids are increased significantly while C20:5-containing lipids are decreased dramatically when normalized to total polar lipids ( Fig.   S7 ). This is consistent with the role of FAT-4 in generating EPA. Furthermore, since our analysis cannot distinguish between eicosatetraenoic acid (ETA, C20:4 n-3) and AA (C20:4 n-6), it is plausible that the increased C20:4 in fat-4 mutants is ETA, as revealed in a previous study (Watts & Browse, 2002) . Moreover, despite the increased level of C20:4-containing lipids, the percentage of C20:4-containing phospholipids is reduced in fat-4 mutants, while the percentage of C20:4containing TAG is increased significantly (Fig. 6A&B) . Therefore, fat-4 mutation reduces the levels of some PUFAs and may also alter the partitioning of PUFAs between phospholipids and TAG.
Compared to fat-4 mutants, the levels of C20:3, C20:4, or C20:5-containing lipids are slightly increased in atgl-1 mutants, when normalized to total polar lipids ( Fig. S7) . Interestingly, consistent with a storage role for LDs, the percentages of C20:3, C20:4, or C20:5-containing TAGs are significantly increased, while the percentages of C20:3, C20:4, or C20:5-containing phospholipids are significantly decreased in atgl-1 mutants (Fig. 6A&B) . Therefore, atgl-1 mutation alters the partitioning of PUFAs into phospholipids and TAG.
In atgl-1; fat-4 double mutants, there were similar changes of C20:3, C20:4 and C20:5 fatty acids as in fat-4 single mutants. However, in the double mutants, we also noticed persistent and further changes in PUFA partitioning between phospholipids and TAG, in particular the partitioning of C20:4. There is a further reduction of the percentage of C20:4-containing phospholipids in atgl-1; fat-4 double mutants compared to either single mutant (Fig. 6A&B) . The altered partitioning of PUFAs between phospholipids and TAG correlates well with the moderate neuroprotective effects in atgl-1 and fat-4 single mutants and the strong neuroprotective effects in atgl-1; fat-4 double mutants.
These results suggest that PUFA-containing phospholipids may promote neurodegeneration.
We further explored the hypothesis that PUFA-containing phospholipids contribute to mec-4(d)-induced neurodegeneration. MBOA-7 incorporates PUFAs into phospholipids, especially PI . We found that mboa-7 mutation alone significantly increased the percentage of mec-4(d) animals with ≥3 surviving touch neurons (from ~5% to ~20%) ( Fig. 6C) .
Moreover, mboa-7 mutation further increases neuron survival in atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d) (Fig. 6C and Fig. S8 ). The enhancement of the neuroprotective effect is probably because the mboa-7 mutation reduces PUFA incorporation into phospholipids. Consistent with that, the percentage of C20:4-containing phospholipids is further decreased in atgl-1(xd314); fat-4(wa14); mboa-7(gk399); mec-4(d) mutants compared with atgl-1(xd314); fat-4(wa14); mec-4(d) mutants (Fig. 6D ). Together, these results indicate that PUFAs promote neuron hyperactivation-mediated neurodegeneration of mec-4(d) through their incorporation into phospholipids.
Discussion
This study addresses two questions: why are there normally no LDs in neurons, and what are the consequences of LD accumulation in neurons? We reveal that the balance of lipolysis and lipogenesis regulates neuronal LD dynamics. In particular, we show that defective ATGL-1/LID-1mediated lipolysis causes LD accumulation autonomously in C. elegans neurons. Defective neuronal lipolysis affects normal gentle touch sensation, while importantly, it alleviates neurodegeneration triggered by neuron hyperactivation. The neuroprotective effect is synergistically enhanced when de novo biosynthesis of PUFA is blocked. Lastly, the incorporation of PUFAs into phospholipids likely underlies neuronal lipolysis and PUFA-mediated neurodegeneration. Therefore, both neuronal LD dynamics and de novo PUFA synthesis regulate the availability of PUFAs, which may be incorporated into phospholipids to maintain the proper function of neurons under normal conditions and to promote neurodegeneration under stress conditions (Fig. 7) .
LDs in neuron: a tug-of-war between lipogenesis and lipolysis
Neurons mainly use glucose to generate energy instead of lipids to avoid extra ROS production by lipid β-oxidation. Although normally there are no LDs in neurons, our results demonstrate that neurons have the ability to form and hydrolyze LDs. Both overexpression of lipogenesis genes and loss of the key lipolysis genes atgl-1 and lid-1 lead to LD accumulation in neurons. It is possible that the lipogenesis in neurons is limited and lipolysis is kept at a relatively high level, which promotes a fast turnover of LDs to meet the lipid requirements of neurons. Thus, there is a tug-of-war between lipogenesis and lipolysis in neurons.
Both atgl-1 and lid-1 are highly conserved from worm to mammals. Previous studies on Drosophila and cultured hippocampal neurons show that instead of forming LDs, neurons transfer the excess lipids into glial cells to form LDs under stress conditions (Bailey et al., 2015 , Ioannou et al., 2019 , Liu et al., 2017 , Liu et al., 2015 . If neurons have the ability to form and hydrolyze LDs, it is puzzling why they do not form LDs themselves. Could the formation of LDs in neurons be worm-specific because most neurons in C. elegans are not surrounded by glial cells? The appearance of LDs in DDHD2 -/mice, which have a defect in a lipase, strongly argues against this possibility (Inloes, Hsu et al., 2014) . Alternatively, it is possible that under conditions of intact neuronal lipolysis, excess lipids can still engage in generating toxic hyperoxidated PUFAs in neurons.
Therefore, to avoid neuronal toxicity, exporting excess lipids to glia is a better choice. Examining the flux of lipid export and lipid incorporation into neutral lipids may provide a further explanation.
Interestingly, mice with deficiencies of ATGL or CGI-58 accumulate massive amounts of neutral lipids in many tissues/organs including brain (Etschmaier, Becker et al., 2011 , Radner, Streith et al., 2010 . Similarly, lipid accumulation in brain was clearly demonstrated in CGI-58 human patients (Huigen, van der Graaf et al., 2015) . However, in both mouse and human studies, there is no direct evidence of LD accumulation in neurons. Compared to LDs in glia or blood vessels, neuronal LDs may be too small to observe and may therefore be neglected. Specific examination of neuronal LDs in these lipolysis-defective mutants will be required to characterize the neuronal defects.
Neuronal lipolysis and neuronal normal function
Here, we show that intact neuronal lipolysis is important for maintaining normal neuron function in worm. Currently, there is no study on neurological function of ATGL-mediated lipolysis in mice. In patients with mutated CGI-58, neurological symptoms, including cognitive impairment and psychiatric disorders, are a frequent characteristic (Schweiger et al., 2009) . A human ATGL mutation case with global cognitive impairment was also reported (Massa et al., 2016) . Therefore, the critical role of neuronal lipolysis in neurons is likely conserved. The detail neuron-specific pathological phenotype and its underlying mechanism remain to be elucidated in ATGL or CGI-58 mouse mutant models and more importantly in human patients.
Our results show that neuronal lipolysis participates in PUFA-mediated touch sensation.
Through incorporation into membrane-forming phospholipids or as signals regulating neuron activity, PUFAs and their derivatives play important roles in neurons (Watts & Ristow, 2017) . In C. elegans mechanical and touch sensation, PUFA-containing phospholipids modulate the activity of particular channels through membrane remodeling and changes of membrane fluidity , Vasquez et al., 2014 . In addition, PUFA depletion causes defects in neurotransmission (Lesa, Palfreyman et al., 2003 , Marza & Lesa, 2006 . It remains to be explored whether the neurological defects in ATGL or CGI-58 human patients are linked to altered PUFAmediated neuronal functions.
Neuronal LDs and neurodegeneration
In this study, we found that LDs have a neuroprotective effect in the neuron hyperactivation- Therefore, the presence of LDs may be beneficial for neurodegenerative diseases in general.
Besides Parkinson's disease, many other neuronal diseases, in particular the HSP diseases, are reported to be accompanied by abnormal levels of neutral lipids, and the disease genes are related to LD dynamics. Knockdown of Spartin, also known as SPG20, increases the number and size of LDs in cells loaded with oleic acid (Papadopoulos et al., 2015) . In another HSP model, DDHD2 -/mice exhibit LD accumulation in neurons (Inloes et al., 2014) . Despite the alteration of LD homeostasis, the role of LD accumulation in neurons under these disease conditions has not been investigated. Our findings also raise the possibility that the accumulation of LDs is a compensatory response to relieve neuronal stress in some HSP diseases. Further studies will be required to explore this possibility.
PUFAs and neurodegeneration
We show that reducing PUFA incorporation into phospholipids has a beneficial effect in alleviating neuronal loss in a neurodegeneration model. The mechanism underlying this effect is not fully clear.
Phospholipids are building blocks of all membranes in mammalian cells, providing the structural integrity that is necessary for protein function. They also serve as precursors for various second messengers such as AA, DHA, ceramide, 1,2-diacylglycerol, IP3, phosphatidic acid, and lysophospholipids (O'Donnell, Rossjohn et al., 2018) . Generally, phospholipids with PUFA chains are more flexible. The cis-double bond lowers the packing density of the acyl chains, which increases membrane fluidity, bending stiffness and effective viscosity (Holthuis & Menon, 2014 , Vasquez et al., 2014 . One possibility is that a reduced level of PUFA-containing phospholipids impacts membrane fluidity and in turn reduces ion-channel activity. For example, AA and DHA can regulate channels such as K + channels and TRPV4 (Caires, Sierra-Valdez et al., 2017 , Horimoto, Nabekura et al., 1997 , Villarroel & Schwarz, 1996 . Moreover, phospholipids with PUFAs can be degraded and produce the second messengers 2-AG, 1,2-diacylglycerol and IP3. Therefore, another possibility is that reduced levels of phospholipids with PUFAs affect downstream signals that execute neurodegeneration triggered by ion-channel hyperactivation.
Our study indicates that reducing the influx of PUFAs into neuron phospholipids protects neurons from degeneration triggered by hyperactivation. This suggests a potential strategy for treating neurodegeneration caused by ion hyperactivation.
Materials and Methods
Strains
Worms were cultured on OP50-seeded nematode growth medium (NGM) plates at 22℃ (Brenner, 1974) CB1611 mec-4(e1611) , VC942 mboa-7(gk399) and GA184 sod-2(gk257) were obtained from the Caenorhabditis Genetics Center (CGC). D1054.1(tm3111) were obtained from the NBRP (Japan). Mutant strains BX24
B0524.2(tm6739) and
fat-1(wa9), BX30 fat-3(wa22) and BX17 fat-4(wa14) were kindly provided by Dr. Bin Liang. lid-1(xd288), atgl-1(xd310) and atgl-1(xd314) were generated by EMS. xdIs182 (Prab-3::Cre/Podr-1::RFP) was generated by integration of Ex(Prab-3::Cre/Podr-1::RFP). atgl-1-loxP(xd426) was generated by CRISPR-Cas9-mediated genome editing. All the transgenic worms were generated by microinjection of the respective plasmids or fosmids with co-injection markers. All the fosmids were kindly provided by Dr. Xiaochen Wang.
Molecular biology
The promoters of Punc-119 (1235bp), Pvha-6 (1808bp), Phlh-17 (2049bp), Pajm-1 (3500bp), Prab-3 (1207bp), Patgl-1 (3004bp) and Pmec-4 (206bp) were amplified from N2 genomic DNA. The coding D1054.1 (801bp) and mboa-2 (1497bp) were amplified from cDNA. The promotor and target cDNA were inserted into plasmid Δpsm. The split GFP1-10 and GFP11 were inserted into pPD95.75. Patgl-1 and Prab-3 were inserted upstream of GFP1-10 and GFP11 respectively. Prab-3::Cre was generated by replacing the eft-3 promotor in pDD104, which was kindly provided by Dr.
Shiqing Cai. atgl-1-sgRNAs for loxP insertion were designed using the Zhang lab's CRISPR design tool at http://crispr.mit.edu to select the target sites. The sgRNAs were inserted into pDD162, which was kindly provided by Dr. Guangshuo Ou. All the constructed plasmids were verified by sequencing.
EMS screen
We treated L4 and young adult xdIs109 (Punc-119::PLIN1::GFP) worms with ethyl methanesulfonate (EMS). About 2,500 F1 were screened. We observed LDs using a Zeiss compound microscope. Mutants were selected that showed LD accumulation in neurons.
SNP mapping and fosmid rescue
We used rapid Single Nucleotide Polymorphism (SNP) mapping (Davis, Hammarlund et al., 2005) .
Briefly, we crossed the mutant with CB4856 and picked F2 animals with LD accumulation. We amplified some SNPs using F2 or F3 lysates as templates and we digested the PCR products with enzymes. After chromosome mapping and interval mapping, we identified a narrow region. Then we did the fosmid rescue assay. Fosmids were injected individually into mutant worms at 5~10 ng/μl together with 50 ng/μl Podr-1::RFP.
Oil red O staining
Oil red O was acquired from Sigma-Aldrich. Oil red O staining was conducted as previously reported (O'Rourke et al., 2009) .
Behavioral assays
Gentle touch sensitivity was tested and scored as described (Hart, 2006 , Vasquez et al., 2014 .
Briefly, we performed ten-trial touch assays. We scored the touch response percentage by stroking an eyebrow across the anterior and posterior body. Twenty-five animals were tested in each trial, and results were compared across three trials. All assays were performed by investigators blinded to genotype and/or treatment.
Quantification of neuron loss
Animals were mounted on thin agarose pads and immobilized by 1-phenoxy-2-propanol (10 μL/mL).
Animals were visualized under a 20X objective. GFP-expressing touch neurons were counted in synchronized L4 animals.
Fatty acid and NAC supplementation
AA (arachidonic acid), and NAC (N-Acetyl-L-cysteine) were acquired from Aladdin. SA (stearic acid), OA (oleic acid), PA (palmitate acid), EPA (eicosapentaenoic acid), LA (linoleic acid) and Tergitol (70%) were acquired from Sigma-Aldrich. FAs, dissolved in ethanol with 0.1% Tergitol, were added to NGM agar to reach a final concentration of approximately 200 mM. NAC was dissolved in ddH2O and added into NGM agar to reach a final concentration of approximately 10 mM. Plates were seeded with E. coli OP50 and kept at room temperature (Vasquez et al., 2014) . For each strain, about 10 L4 worms were placed on the plate. We quantified the phenotype in the next generation.
Stimulated Raman Scattering (SRS) microscopy
To quantify lipid droplet metrics in the touch neurons, 1-day adult worms were imaged using Stimulated Raman Scattering (SRS) microscopy. Worms were mounted onto 2% agarose pads with 0.5% NaN3 as anesthetic on glass microscope slides and imaged using a 60× water objective (UPlanAPO/IR; 1.2 N.A.; Olympus). A femtosecond-pulsed laser and picosecond-pulsed laser were used for simultaneously imaging label-free lipids (SRS channel) and GFP-labeled neurons (fluorescence channel). Images were analyzed using ImageJ software (NIH). Neuronal area was selected using fluorescent signal based on several Z-projected stacks to confirm the presence of lipid droplets within the cell and to exclude extracellular signal.
EM analysis
Young adult worms were collected for high-pressure freezing and freeze-substitution, embedding and sectioning following a procedure essentially as described by (Weimer, 2006) . Then the sections were visualized with a Hitachi HT7700 and pictures were recorded on a 4008 × 2672 CCD camera.
Lipidomic analysis
Worms were washed 9~10 times in M9. More than 10,000 worms per genotype were collected per sample and 5 samples were analyzed per genotype. Lipid extraction and analysis were conducted as previously reported (Lam, Wang et al., 2014) . The lipid content was normalized by the mole fraction of each lipid to total polar lipids.
Statistical analyses
All data are presented as mean ± SEM. The data were first analyzed using one-way ANOVA or twoway ANOVA and for statistically significant overall results. Post hoc multiple comparison tests were carried out to determine significant differences. Significant difference is noted with a number sign (#) or an asterisk (*). ns represents not statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001. Fig. 1 lid-1(xd288) and atgl-1(xd314) display ectopic LD accumulation in neurons. (E) Mutants of LID-1 or ATGL-1 paralogs do not affect LD dynamics in neurons. Each dot represents one worm. The data was analyzed using one-way ANOVA with Dunnett's multiple comparison test. * denotes the significant difference as compared to the control xdIs109. Error bars, SEM. n ≥ 9. ns: not statistically significant.
(F) Neuronal expression of LID-1 and ATGL-1 paralogs do not rescue lid-1(xd288) or atgl-1(xd314).
Each dot represents one worm. The data was analyzed using one-way ANOVA with Tamhane's T2 multiple comparison test. * signifies the significant difference between the groups under the crossbar. Error bars, SEM. n ≥ 9. ns: not statistically significant. Fig. 4 atgl-1(xd314) and lid-1(xd288) show gentle touch sensation defect.
(A) LDs accumulate in touch neurons in atgl-1(xd314) visualized by SRS (Stimulated Raman scattering). The zdIs5 reporter marks touch neurons. This shows that there is LD accumulation in touch neurons in atgl-1(xd314). Scale bar: 10 μm.
(B) atgl-1(xd314) and lid-1(xd288) show gentle touch sensation defect, which could be rescued by the neuron-specifically expression of atgl-1 and lid-1, respectively. The mutation of fat-4 enhances the touch sensation defect in atgl-1(xd314) and lid-1(xd288). The data was analyzed using one-way ANOVA with Turkey's multiple comparison test. * denotes the significant difference as compared to the control N2. "NS" and "#" signify the significant difference between the groups under the crossbar. Error bars, SEM. n =25. (D) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds. Mutants of fat-1, fat-3 and fat-4 significantly enhance the suppression effect of atgl-1(xd314) in preventing the neurodegeneration of mec-4(d). The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test. # denotes the significant difference as compared to atgl-1(xd314); mec-4(d) . * signifies the significant difference as compared to mec-4(d) .
Error bars, SEM. Number of experiments n ≥ 3, with at least 50 animals per strain analyzed in each experiment.
(E) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds supplemented with different fatty acids. AA and EPA but not LA significantly enhance the neurodegeneration triggered by mec-4(d). The data was analyzed using one-way ANOVA with Dunnett's multiple comparison test. "ns" and "*" signify the significant difference between the groups under the crossbar. Error bars, SEM. Number of experiments n ≥ 3, with at least 50 animals per strain analyzed in each experiment. Fig. 6 PUFA containing phospholipids regulate neurodegeneration of mec-4(d) .
(A) The percentage of C20:3-, C20:4-or C20:5-containing TAGs to total lipids containing according PUFA in different genetic backgrounds. The percentage of C20:4-containing TAGs to total lipids containing C20:4 is significantly increased in atgl-1 and fat-4 single mutants. The percentage is further increased in atgl-1 and fat-4 double mutant.
(B) The percentage of C20:3-, C20:4-or C20:5-containing phospholipids to total lipids containing according PUFA in different genetic backgrounds. The percentage of C20:4-containing phospholipids to total lipids containing C20:4 is significantly decreased in atgl-1 and fat-4 single mutants. The percentage is further decreased in atgl-1 and fat-4 double mutant.
(A-B) FFA: free fatty acids; TAG: triacylglycerol; PL: phospholipids. The data was analyzed using two-way ANOVA with Dunnett's multiple comparison test. * signifies the significant difference as compared to mec-4(d) . Error bars, SEM. n=5. ns: not statistically significant.
(C) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds. mboa-7 mutation significantly increases the percentage of three and more surviving touch neurons in mec-4(d), atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d) . The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test. "*" signifies the significant difference between the groups under the crossbar. Error bars, SEM. n ≥ 4. ns: not statistically significant.
(D) The percentage of C20:4-containing phospholipids to total lipids that have C20:4 is dramatically decreased in mboa-7(gk399); atgl-1(xd314); fat-4(wa14); mec-4(d) .
The data was analyzed using one-way ANOVA with Dunnett's multiple comparison test. * signifies the significant difference as compared to mec-4(d) . Error bars, SEM. n=5. bp atgl-1(+) rescues the phenotype of atgl-1(xd314). Each dot represents one worm. The data was analyzed using one-way ANOVA with Dunnett's multiple comparison test. * signifies the significant difference as compared to control xdIs109. Error bars, SEM. n ≥ 9. ns not statistically significant.
(C) LoxP were inserted into the two sides of atgl-1 locus. To identify atgl-1 deletions, primer F and primer R were used to amplify atgl-1 locus. There is only one band in negative control Ex(Prab-3::Cre/Podr-1::RFP) and atgl-1-loxP(xd426). There are two bands (one large and one small) in atgl-1-loxP(xd426); Ex(Prab-3::Cre/Podr-1::RFP), indicating that atgl-1 is partially deleted. -4(d) .
The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds supplemented with fatty acid mix. The supplement of PA, SA and OA don't affect the neurodegeneration triggered by mec-4(d). The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test. ns: not statistically significant. Error bars, SEM. Number of experiments n ≥ 3, with at least 50 animals per strain analyzed in each experiment.
Fig. S6 Manipulating ROS scavengers doesn't influence protective effect of lipolysis mutants or
PUFA mutants in neurodegeneration caused by mec-4(d)
(A) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds. sod-2 mutation doesn't enhance neurodegeneration in mec-4(d), atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d) . The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test. Error bars, SEM. ns: not statistically significant. Number of experiments n ≥ 5, with at least 50 animals per strain analyzed in each experiment.
(B) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds. Using touch neuron specific promoter Pmec-4 driving sod-1, sod-2, sod-3 or sod-4 overexpression in touch neurons doesn't significantly affect neurodegeneration in mec-4(d). The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test. Error bars, SEM. ns: not statistically significant. Number of experiments n ≥ 2, with at least 50 animals per strain analyzed in each experiment.
(C) The percentage of worms that have three or more surviving touch neurons in different genetic backgrounds. Feeding worms with antioxidant NAC doesn't significantly affect neurodegeneration in mec-4(d), atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d). The data was analyzed using one-way ANOVA with Bonferroni's multiple comparison test.
Error bars, SEM. ns: not statistically significant. Number of experiments n ≥ 5, with at least 50 animals per strain analyzed in each experiment.
Fig. S7
The relative content of lipids that have C20:3, C20:4 or C20:5 PUFAs.
(A) Lipidomic data show that the relative content of total C20:3 is increased in atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d), especially in mutants that have fat-4 mutation.
(B) Lipidomic data show that the relative content of total C20:4 is increased in atgl-1(xd314); mec-4(d), fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d), especially in mutants that have fat-4 mutation.
(C) Lipidomic data show that the relative content of total C20:5 is slightly increased in atgl-1(xd314); mec-4(d) but a dramatically decreased in fat-4(wa14); mec-4(d) and atgl-1(xd314); fat-4(wa14); mec-4(d) , which matches the role of FAT-4 in synthesizing C20:5 (EPA).
(A-C) The data was analyzed using one-way ANOVA with Dunnett's multiple comparison test. * signifies the significant difference as compared to control mec-4(d). Error bars, SEM. n=5. Fig. S8 mboa-7 mutation significantly affects neurodegeneration caused by mec-4(d) .
(A) Image of touch neurons in worms viewed by zdIs5 
